~500
Employees
A global biotechnology company partnered with EFESO to reduce lead times and optimize inventory across Quality, Manufacturing, and CDMO operations. By leveraging cross-functional collaboration, detailed process mapping, and data-driven recommendations, the program achieved significant reductions in batch record lead times, inventory levels, and stock obsolescence risk.
Industry: Life Sciences
Service: Manufacturing
Service: Operations Strategy and Transformation
Service: Supply Chain
The client is a global biotechnology company dedicated to the research, development, and commercialization of therapies for rare and severe diseases. With a strong focus on patient-centered innovation, the organization operates at the forefront of advanced biologic and genetic treatments.
~500
Employees
+500M
Annual revenue
+20
Countries in global footprint
Our client’s contract manufactured supply chain had long E2E lead times of between 18-24 months and was holding significant volumes of inventory. Our client was in the early stages of a new product launch and were anticipating volumes to ramp up considerably in the near term. EFESO were asked to understand and resolve the performance shortfalls in the existing supply chain and ensure the future supply chain is designed to minimize lead time and inventory.
Key challenges navigated while delivering the project include:
The EFESO-led program enabled the client to achieve measurable improvements in lead times, inventory levels, and stock risk management, while fostering cross-functional collaboration.
-60%
Reduction in lead time
-45%
Inventory reduction
$9M
Risk of stock obsolescence mitigated
EFESO implemented a structured program combining human dynamics, data analysis, and operational process mapping to enable sustainable improvements.